The role of antithrombotic therapy on the patency of peripheral bypasses

Vasa - Journal of Vascular Diseases

Volumn 29, Issue 3, 2000, Pages 163-167

  Bucek, R A ^a   Schnurer, G ^a   Ahmadi, A ^a   Polterauer, P ^a   Kretschmer, G ^a   Minar, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anticoagulation; Antiplatelet drugs; Peripheral arterial occlusive disease; Peripheral bypasses; Vascular surgery

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; DEXTRAN; DIPYRIDAMOLE; ESTROGEN; HEPARIN; LOW DENSITY LIPOPROTEIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; TICLOPIDINE; TISSUE FACTOR PATHWAY INHIBITOR; WARFARIN;

ANTICOAGULANT THERAPY; BYPASS SURGERY; CLINICAL TRIAL; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; GENE THERAPY; GRAFT PATENCY; HUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROPHYLAXIS; REVIEW; THROMBOSIS;

EID: 0033812854     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.29.3.163     Document Type: Review

References (42)

1. Collaborative overview of randomized trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
2. Collaborative overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
3. Influence of Coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery
4. Effect of Ticlopidine on the long-term patency of saphenous vein bypass grafts in the legs
5. Guidelines for the management of patients with valvular heart disease
6. Human saphenous vein bypass grafts: Immune response
7. Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts
8. Antiplatelet therapy and patency of saphenous vein bypass grafts in the legs
9. The influence of platelet inhibition on the patency of femoro-popliteal Dacron Bypass grafts
10. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): A randomized trial
11. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting
12. Aspirin usage and its influence on femoro-popliteal vein graft patency. The Femoro-popliteal Bypass Trial Participants
13. Does 11 lindium-platelet deposition predict patency in prosthetic arterial grafts?
14. Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency
15. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety
16. Antithrombotic therapy in peripheral arterial occlusive disease
17. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts
18. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis
19. Influence of postoperative anticoagulant treatment on patient survival after femoropopliteal vein bypass surgery
20. Hemorrhagic Complications of Anticoagulant Treatment
21. Antithormboltic drug therapy after infrainguinal vascular surgery
22. Pharmacological Prophylaxis against postoperative graft occlusion after peripheral vascular surgery: A worldwide survey
23. Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial
24. Published results of surgery for aortoiliac occlusive disease
25. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-center, randomized controlled trial
26. Mechanisms of Disease: The protective effect of estrogen on the cardiovascular system
27. Infrainguinal revascularisation in the era of vein-graft surveillance - Do clinical factors influence long-term outcome?
28. Management of patients with atrial fibrillation
29. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets: Effect of dipyridamole and aspirin
30. Lipid-lowering interventions in angiographic trials
31. The efficacy of dextran 40 in preventing early post-operative thrombosis following difficult lower extremity bypass
32. Vascular smooth muscle cell proliferation: Basic investigators and new therapeutic approaches
33. Low-molecular-weight heparin vs. Unfractioned heparin in femorodistal reconstructive surgery: A multicenter open randomized study
34. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure
35. Avioding early failure of tibial prosthetic bypass grafts
36. The antiplatelet effects of ticlopidine and clopidogrel
37. Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery
38. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions
39. Heparin and protamine use in peripheral vascular surgery: A comparison between surgeons of the Society for Vascular Surgery and the European Society for Vascular Surgery
40. Adjuvant medical therapy in peripheral bypass surgery
41. Stellenwert einer gerinnung-shemmenden Medikation nach supraaortalen Bypassen zur Revaskularisierung der Arteria subclavia